.webp)
Turns weeks of manual protein analysis into minutes for drug development teams.
Company Overview
Competitors
Legacy Instrument Software
Thermo BioPharmaFinder, Waters UNIFI, Bruker.
Specialized Protein Analytics
Protein Metrics (Byos/PMI), PEAKS (BSI).
Open-Source
MaxQuant, MSFragger/FragPipe, OpenMS.
10xScience
's Moat:
How They're Leveraging AI
AI Use Overview:
Using AI that automates peptide mapping, detects rare protein modifications, and normalizes mass spec data across different lab instruments into one view.
CellType
Simulates human biology with AI to predict drug effects and run virtual trials.
Google CEO Sundar Pichai highlighted their C2S-Scale 27B model for generating a novel cancer hypothesis that was later validated experimentally. CellType simulates human biology to predict drug effects using foundation models presented at ICML 2024, with all deals coming inbound from top-10 pharma. Yale professor turned down Google to build it.
Ditto Biosciences
Mines parasite genomes to discover protein therapeutics for autoimmune diseases.
Parasites evolved to suppress human immune responses over millions of years. Ditto mines their genomes for immunomodulatory proteins, and over 98% of those proteins remain uncharacterized. Three PhDs from Harvard, Berkeley, and UCSF with 40+ years of combined expertise in host-parasite biology.
Mango Medical
Automates surgical planning for orthopedic procedures from CT scans using agentic AI.
Surgical planning for shoulder replacements takes hours of manual CT scan interpretation. Mango automates it in seconds via API, already past $500K ARR before demo day, with an 8-figure LOI from a leading orthopedic company. Only company in YC W26 pursuing FDA 510(k) clearance.
Origin
Designs regulatory DNA that outperforms DeepMind for safer, more precise gene therapies.
Gene therapies need precise regulatory DNA elements to control where and when genes express. Origin's Axis model outperforms DeepMind's AlphaGenome by 6.7% on activity prediction, with free API access for researchers and pharma partnerships forming.
